Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development

Abstract

Background mRNA became a promising therapeutic approach in many diseases. This study aimed to identify the tumor antigens specifically expressed in tumor cells for lower-grade glioma (LGG) and glioblastoma (GBM) patients. Methods In this work, the mRNA microarray expression profile and clinical data were obtained from 301 samples in the Chinese Glioma Genome Atlas (CGGA) database, the mRNA sequencing data and clinical data of 701 samples were downloaded from The Cancer Genome Atlas (TCGA) database. Genetic alterations profiles were extracted from CGGA and cBioPortal datasets. R language and GraphPad Prism software were applied for the statistical analysis and graph work. Results PTBP1 and SLC39A1, which were overexpressed and indicated poor prognosis in LGG patients, were selected as tumor-specific antigens for LGG patients. Meanwhile, MMP9 and SLC16A3, the negative prognostic factors overexpressed in GBM, were identified as tumor-specific antigens for GBM patients. Besides, three immune subtypes (LGG1-LGG3) and eight WGCNA modules were identified in LGG patients. Meanwhile, two immune subtypes (GBM1–GBM2) and 10 WGCNA modules were selected in GBM. The immune characteristics and potential functions between different subtypes were diversity. LGG2 and GBM1 immune subtype were associated with longer overall survival than other subtypes. Conclusion In this study, PTBP1 and SLC39A1 are promising antigens for mRNA vaccines development in LGG, and MMP9 and SLC16A3 were potential antigens in GBM. Our analyses indicated that mRNA vaccine immunotherapy was more suitable for LGG2 and GBM1 subtypes. This study was helpful for the development of glioma immunotherapies.

mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses

“…Subsequently, 255 studies were enrolled, the characteristics of each study were shown in Supplementary Table 2 . Among these, 161 studies were conducted in China [ 16 , 18 , 20 – 21 , 23 – 29 , 31 , 34 , 36 – 37 , 40 – 44 , 47 – 48 , 50 , 53 , 55 , 64 , 66 – 69 , 71 – 74 , 80 , 82 – 87 , 89 , 92 – 95 , 97 – 98 , 102 – 105 , 107 , 109 – 113 , 115 – 118 , 120 – 124 , 126 – 127 , 135 – 137 , 139 – 144 , 146 – 152 , 154 – 155 , 157 , 160 – 164 , 166 , 168 – 170 , 172 – 173 , 177 – 179 , 184 – 190 , 193 – 195 , 197 – 197 , 206 – ...…”